Litcius/Paper detail

Pulmonary Surfactant Homeostasis Dysfunction Mediates Multiwalled Carbon Nanotubes Induced Lung Fibrosis <i>via</i> Elevating Surface Tension

Xin Li, Jianzhong Zhang, Mingyue Wang, Chao Du, Wenjing Zhang, Yingying Jiang, Wanjun Zhang, Xinmin Jiang, Dunqiang Ren, Hongmei Wang, Xinru Zhang, Yuxin Zheng, Jinglong Tang

2023ACS Nano13 citationsDOI

Abstract

Multiwalled carbon nanotubes (MWCNTs) have been widely used in many disciplines and raised great concerns about their negative health impacts, especially environmental and occupational exposure. MWCNTs have been reported to induce fibrotic responses; however, the underlying mechanisms remain largely veiled. Here, we reported that MWCNTs inhalation induced lung fibrosis together with decreased lung compliance, increased elastance in the mice model, and elevated surface tension in vitro . Specifically, MWCNTs increased surface tension by impairing the function of the pulmonary surfactant. Mechanistically, MWCNTs induced lamellar body (LB) dysfunction through autophagy dysfunction, which then leads to surface tension elevated by pulmonary surfactant dysfunction in the context of lung fibrosis. This is a study to investigate the molecular mechanism of MWCNTs-induced lung fibrosis and focus on surface tension. A direct mechanistic link among impaired LBs, surface tension, and fibrosis has been established. This finding elucidates the detailed molecular mechanisms of lung fibrosis induced by MWCNTs. It also highlights that pulmonary surfactants are expected to be potential therapeutic targets for the prevention and treatment of lung fibrosis induced by MWCNTs.

Topics & Concepts

Pulmonary fibrosisLungFibrosisPulmonary surfactantContext (archaeology)Lamellar granuleIdiopathic pulmonary fibrosisSurface tensionCompliance (psychology)Pulmonary compliancePathogenesisMedicineMaterials scienceChemistryImmunologyPathologyBiologyInternal medicineBiochemistryPsychologySocial psychologyQuantum mechanicsPhysicsPaleontologyOccupational and environmental lung diseasesInhalation and Respiratory Drug DeliveryInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis